Clinical Edge Journal Scan

Clinical Edge Journal Scan

Commentary: Renal Disease in Type 2 Diabetes, November 2022

Publish date: October 29, 2022

• Read More

Clinical Edge Journal Scan

Lower serum bile acid levels independently predict adverse renal outcomes in T2DM and DKD

Publish date: October 23, 2022

• Read More

Clinical Edge Journal Scan

No increase in risk for major adverse limb events with SGLT-2i vs. GLP-1RA in T2DM

Publish date: October 23, 2022

• Read More

Clinical Edge Journal Scan

Adding antihypertensive to standard diabetes therapy improves glycemic control in T2DM

Publish date: October 23, 2022

• Read More

Clinical Edge Journal Scan

Metformin ups gastrointestinal adverse event risk in T2D

Publish date: October 23, 2022

• Read More

Clinical Edge Journal Scan

Metformin may offer more neuroprotection for dementia than sulfonylurea in T2D

Publish date: October 23, 2022

• Read More

Clinical Edge Journal Scan

Saxagliptin add-on to oral antihyperglycemic agents safe and effective in drug-naive T2D patients

Publish date: October 23, 2022

• Read More

Clinical Edge Journal Scan

T2D: Bexagliflozin add-on to metformin shows antidiabetic potency equivalent to glimepiride

Publish date: October 23, 2022

• Read More

Clinical Edge Journal Scan

T2D: Increased risk for ventricular arrhythmia or sudden cardiac death with sulfonylurea vs metformin

Publish date: October 23, 2022

• Read More

Clinical Edge Journal Scan

Antidiabetic drugs influence fracture risk in T2D

Publish date: October 23, 2022

• Read More

Pages

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• last »